Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Axsome Therapeutics (AXSM) Return on Assets (2022 - 2025)

Historic Return on Assets for Axsome Therapeutics (AXSM) over the last 4 years, with Q3 2025 value amounting to 0.35%.

  • Axsome Therapeutics' Return on Assets rose 2100.0% to 0.35% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.35%, marking a year-over-year increase of 2100.0%. This contributed to the annual value of 0.5% for FY2024, which is 200.0% up from last year.
  • According to the latest figures from Q3 2025, Axsome Therapeutics' Return on Assets is 0.35%, which was up 2100.0% from 0.4% recorded in Q2 2025.
  • Axsome Therapeutics' Return on Assets' 5-year high stood at 0.33% during Q3 2023, with a 5-year trough of 0.56% in Q2 2024.
  • For the 4-year period, Axsome Therapeutics' Return on Assets averaged around 0.46%, with its median value being 0.46% (2023).
  • As far as peak fluctuations go, Axsome Therapeutics' Return on Assets tumbled by -2300bps in 2024, and later skyrocketed by 2100bps in 2025.
  • Over the past 4 years, Axsome Therapeutics' Return on Assets (Quarter) stood at 0.56% in 2022, then grew by 28bps to 0.4% in 2023, then dropped by -26bps to 0.51% in 2024, then surged by 31bps to 0.35% in 2025.
  • Its Return on Assets was 0.35% in Q3 2025, compared to 0.4% in Q2 2025 and 0.48% in Q1 2025.